| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/12/2004 | WO2002046411A3 Intestinal proteins |
| 02/12/2004 | WO2002012443A8 Active nems arrays for biochemical analyses |
| 02/12/2004 | WO2001069413A3 Process for storing data |
| 02/12/2004 | US20040030504 System, method, and computer program product for the representation of biological sequence data |
| 02/12/2004 | US20040030503 Neural -network-based identification, and application, of genomic information practically relevant to diverse biological and sociological problems, including susceptibility to disease |
| 02/12/2004 | US20040030502 Process for storing data |
| 02/12/2004 | US20040030404 Method for cultivating a cartilage replacement and a biomatrix produced according to this method |
| 02/12/2004 | US20040030353 System for withdrawing body fluid |
| 02/12/2004 | US20040030264 Method and apparatus for analyzing mammary gland fluid |
| 02/12/2004 | US20040030228 Method and kit for the transderaml determinaton of analyte concentration in blood |
| 02/12/2004 | US20040030112 Use of these kinases as targets for isolating specific inhibitors or antagonists of the kinase activity, the inhibitors are anticipated to have use as contraceptive agents |
| 02/12/2004 | US20040029837 Red fluorescence dyes; labels |
| 02/12/2004 | US20040029822 Detecting moderator of human chromosomes; calibration; genetic engineering; screening for nervous system defects in mammals |
| 02/12/2004 | US20040029808 Binding antibody to estradiol; test device |
| 02/12/2004 | US20040029804 Novel potassium channel |
| 02/12/2004 | US20040029800 Remedies for obesity and obesity-associated diseases and method of evaluating these remedies |
| 02/12/2004 | US20040029795 Gene which modulate gene expression of protein |
| 02/12/2004 | US20040029794 Immobilizated growth hormone releasing factor |
| 02/12/2004 | US20040029791 Polypeptides; antitumor agents; suppression phosphorylation |
| 02/12/2004 | US20040029778 Prostate specific antigen; immobilization; antiproliferative agents; drug delivery |
| 02/12/2004 | US20040029775 Methods and compounds for influencing beta3-integrin-dependent intracellular processes |
| 02/12/2004 | US20040029773 Potassium channel moderators |
| 02/12/2004 | US20040029770 Genetic engineering; anticancer agents |
| 02/12/2004 | US20040029739 Determining the pvt properties of a hydrocarbon reservoir fluid |
| 02/12/2004 | US20040029554 Method for histocompatibility testing |
| 02/12/2004 | US20040029295 Use of edible micro particles to tag or mark edible products such as foodstuffs |
| 02/12/2004 | US20040029294 Method for determination of the origin and authenticity of materials with biological, biochemical and nutritional physiological relevance |
| 02/12/2004 | US20040029293 Automated immunoassay cassette, apparatus and method |
| 02/12/2004 | US20040029292 Proteins to be analyzed is degraded to peptide fragments corresponding to the peptide epitopes, after which the array of capture molecules is incubated with the peptide fragments |
| 02/12/2004 | US20040029291 Method for separating a dispersed or dissolved substance and magnet separator |
| 02/12/2004 | US20040029290 New fluorescent metal complexes, methods for their preparation and methods for labelling target materials |
| 02/12/2004 | US20040029287 Selective and rapid room temperature derivatization of conjugated dienes by 4- methyl-1, 2, 4-triazoline-3, 5-dione (MTAD) followed by Chemical ionization GC/MS and GC/NCD analyses |
| 02/12/2004 | US20040029286 C-reactive protein (CRP) |
| 02/12/2004 | US20040029261 Methods for conducting assays and devices for use therein |
| 02/12/2004 | US20040029259 Method and system for the detection of cardiac risk factors |
| 02/12/2004 | US20040029258 Methods and devices for performing chemical reactions on a solid support |
| 02/12/2004 | US20040029255 The use of primers to detect specific isolates of fungal pathogens and the monitoring of disease development in plants; Colletotrichum acutatum, Alternaria spp., and Cladosporium carpophilum |
| 02/12/2004 | US20040029247 Regulation of human adenylate cyclase, type iv |
| 02/12/2004 | US20040029246 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 02/12/2004 | US20040029244 Phospholipase d effectors for therapy and screening |
| 02/12/2004 | US20040029241 Formulation and use of a polymerization process employing biocompatible polymers and biocompatible polymerization conditions, such as neutral pH, where there is maintenance of an aqueous environment |
| 02/12/2004 | US20040029232 Novel G-protein coupled receptors |
| 02/12/2004 | US20040029224 Used for determination of ligands (agonists), preparation of antibodies and antisera, construction of recombinant receptor protein expression systems, development of receptor binding assay systems and screening of pharmaceutical candidates |
| 02/12/2004 | US20040029223 Two bacterial strains deficient in endogenous adenylate cyclase activity are used in a signal amplification system comprising a bacterial multi-hybrid system |
| 02/12/2004 | US20040029221 Identification and isolation of novel DNA and the recombinant production of novel polypeptides; for detecting the presence of tumors in mammals |
| 02/12/2004 | US20040029217 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/12/2004 | US20040029216 Used to treat blood, brain, urogenital, nervous system, sexual, bone, cardiovascular, gastrointestinal, skin disorders, cancer, bacterial/viral/fungi infections |
| 02/12/2004 | US20040029210 Assay for paralytic shellfish toxin |
| 02/12/2004 | US20040029208 Assay method and kit for testing biological material for exposure to stress using biomarkers |
| 02/12/2004 | US20040029207 Cycclooxygenase-2 (COX-2); detecting and measuring COX-2 specific ammino acid eicosanoid metabolites, prostaglandinH2-glycine and/or hydroxy eicosatetranoic-glycine; COX-2 selective substrates |
| 02/12/2004 | US20040029206 Phosphatidylinositol bisphosphate (PIP2) indicatorof membrane molecules using fluorescence resonance energy transfer (FRET) |
| 02/12/2004 | US20040029203 Method for preventing chemical crosstalk in enzyme-linked reactions using a microreaction array having at least two reaction chambers for receiving substances which react chemically or biochemically with other substances |
| 02/12/2004 | US20040029202 By determining a level of an estrogen- related marker; screening patient for hormone replacement therapy (HRT), and of monitoring such patients once they begin HRT; treating peri-, menopausal or postmenopausal women |
| 02/12/2004 | US20040029201 Identification of targets of antimicrobial compounds |
| 02/12/2004 | US20040029200 Method and kits for the detection of renal cell carcinoma in a biological fluid of a patient |
| 02/12/2004 | US20040029199 Human cervical cancer 2 protooncogene and protein encoded therein |
| 02/12/2004 | US20040029198 For diagnosing breast cancer, neurological disorders, and heart disease through quantitative analysis; in vitro bioassays; kits |
| 02/12/2004 | US20040029197 Novel human cancer/testis antigen and gene thereof |
| 02/12/2004 | US20040029196 Used in drug screening for anticancer/antitumor agents; tumor suppressor genes |
| 02/12/2004 | US20040029195 Compositions and methods for cancer screening |
| 02/12/2004 | US20040029194 Method of identifying cancer markers and uses therefor in the diagnosis of cancer |
| 02/12/2004 | US20040029193 Comprises monodisperse polymer particles of human albumin, fibrin, fibrinogen or polyphenylmethacrylate for quantitative measuring of the adhesion of platelets in vitro |
| 02/12/2004 | US20040029192 By detecting polymorphisms associated with CD2AP protein; gel electrophoresis; fluorescence resonance energy transfer |
| 02/12/2004 | US20040029191 Detection of kinase substrates and products using ion mass spectrometry |
| 02/12/2004 | US20040029190 Automated methods of detecting receptor activity |
| 02/12/2004 | US20040029189 Comprises incubating target cells containing membrane-bound/marker protein encoding genes that induces apoptosis and detecting protein that leaks out of cells |
| 02/12/2004 | US20040029188 Method for the detection of human hematopoietic short term repopulating cells |
| 02/12/2004 | US20040029187 Systems and methods for detection of nuclear receptor function using reporter enzyme mutant complementation |
| 02/12/2004 | US20040029186 Methods |
| 02/12/2004 | US20040029185 Interaction of tbx2 and the arf promoter in cell cycle regulator assays |
| 02/12/2004 | US20040029183 Biosensors/receptors; for detecting chemical and biological weapons; photocells |
| 02/12/2004 | US20040029181 Novel metal complex and method for determining amino acid sequence of protein using the same |
| 02/12/2004 | US20040029180 Method for identifying agonists or antagonists of the G protein-coupled receptor mas-like 1 |
| 02/12/2004 | US20040029177 Biosensor and measurement method |
| 02/12/2004 | US20040029176 By measuring metalloproteinase-8 (MMP-8) concentration in amniotic fluid; uterine infections; kits |
| 02/12/2004 | US20040029175 By detecting levels of intact albumin in urine; for treatment of diabetes |
| 02/12/2004 | US20040029174 End selection in directed evolution |
| 02/12/2004 | US20040029172 Generation of combinatorial libraries and assessment thereof by deconvolution |
| 02/12/2004 | US20040029171 For the detection of caries-causing and/or parodontitis-causing bacteria, which can be found in gum pocket fluid |
| 02/12/2004 | US20040029169 Nogo Receptor (NgR)-p75; myelins; for drug screening; cell-free |
| 02/12/2004 | US20040029168 Employing micro-array format; for use on human tissues |
| 02/12/2004 | US20040029162 By carrying out a specific reaction of binding (hybridization) of said analyte with a ligand specific for this analyte, and determining the binding reaction by means of at least two fluorescent labels present on the analyte |
| 02/12/2004 | US20040029159 Cell lineage determination and genetic switches and mobile element related genes and their role in genetic programming during development or cell lineage decisions |
| 02/12/2004 | US20040029156 Immobilization of biomolecules on substrates by attaching them to adsorbed bridging biomolecules |
| 02/12/2004 | US20040029153 Method for estimating metabolic function of xenobiotic and induction thereof |
| 02/12/2004 | US20040029152 Fluorescent analysis element with the use of metallic nanowell and process for producing the same |
| 02/12/2004 | US20040029150 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/12/2004 | US20040029149 Human metabolic models and methods |
| 02/12/2004 | US20040029147 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 02/12/2004 | US20040029139 System for simultaneous detection of multiple binding events in the same reaction |
| 02/12/2004 | US20040029135 Biological and chemical warfare agents (BCWA); detecting a target analyte protecting a specific target analyte in a sample, eliminating non-specific analytes, and detecting the presence of target with a signal |
| 02/12/2004 | US20040029134 P53-associated Parkin-like cytoplasmic protein, and related compositions and methods |
| 02/12/2004 | US20040029131 A system and a process incorporating SKM for analysis of biomolecule interactions on a substrate surface |
| 02/12/2004 | US20040029128 Analyzing methylation patterns; cell proliferation; cancer diagnosis |
| 02/12/2004 | US20040029124 Generation hybrid Dna using primers and ligase; analyzing gene expression patterns |
| 02/12/2004 | US20040029123 Diagnosis of diseases associated with the cell cycle |
| 02/12/2004 | US20040029122 Using mitochrondria Dna sequences; diabetes diagnosis |
| 02/12/2004 | US20040029120 Method of non-targeted complex sample analysis |
| 02/12/2004 | US20040029118 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments |
| 02/12/2004 | US20040029117 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the DNA |